AdvaMed’s Medical Innovation Agenda for the 118th Congress
AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Health Equity
Women and Heart Disease
Heart attack symptoms in women can be different than in men and less well-known as heart attack-related. Women need their heart disease recognized and treated on equal footing with men.
AdvaMed’s Top 10 Medtech Wins in 2022
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
“Do it”: Breast Cancer Screening Saves Lives
October is Breast Cancer Awareness Month and a good time to remember the importance of diagnostic screenings in saving lives.
AdvaMed Responds to CMS’ Request for Information Regarding Medicare Advantage
AdvaMed submitted a letter to CMS’s RFI on Medicare regarding ways to strengthen the Medicare Advantage program to align with the Vision for Medicare and CMS’ Strategic Pillars.
AdvaMed Welcomes Progress for Medtech Patients at Summit of the Americas
The Advanced Medical Technology Association, AdvaMed, today welcomed several outcomes of the just-concluded IX Summit of the Americas in Los Angeles.
In New Report, AdvaMed Seeks Ways to Increase Diversity in Clinical Research and Addressing Health Equities
The Advanced Medical Technology Association (AdvaMed) released a report titled “Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities”, a new document intended to outline considerations and approaches…
Increasing Diversity in Clinical Research and Addressing Health Inequities
This document is intended to outline some of the potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.
Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities
Based on insights from a related workshop series, this document outlines potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.